Home › Dermatomyositis › Colorado › Aurora
Dermatomyositis clinical trials in Aurora, CO
3 studies for Dermatomyositis are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, Aurora
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- Children's Hospital Colorado - Accepting Juvenile Patients, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Colorado Denver, Aurora
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- New York City, NY5 studies
- Pittsburgh, PA5 studies
- Houston, TX5 studies
- Boston, MA5 studies
- Baltimore, MD4 studies
- Philadelphia, PA4 studies
- Miami, FL4 studies
- Kansas City, KS3 studies
- Jacksonville, FL3 studies
- Phoenix, AZ3 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Ovarian Cancer24 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.